» Articles » PMID: 33991694

Deep Recurrent Model for Individualized Prediction of Alzheimer's Disease Progression

Overview
Journal Neuroimage
Specialty Radiology
Date 2021 May 15
PMID 33991694
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is known as one of the major causes of dementia and is characterized by slow progression over several years, with no treatments or available medicines. In this regard, there have been efforts to identify the risk of developing AD in its earliest time. While many of the previous works considered cross-sectional analysis, more recent studies have focused on the diagnosis and prognosis of AD with longitudinal or time series data in a way of disease progression modeling. Under the same problem settings, in this work, we propose a novel computational framework that can predict the phenotypic measurements of MRI biomarkers and trajectories of clinical status along with cognitive scores at multiple future time points. However, in handling time series data, it generally faces many unexpected missing observations. In regard to such an unfavorable situation, we define a secondary problem of estimating those missing values and tackle it in a systematic way by taking account of temporal and multivariate relations inherent in time series data. Concretely, we propose a deep recurrent network that jointly tackles the four problems of (i) missing value imputation, (ii) phenotypic measurements forecasting, (iii) trajectory estimation of a cognitive score, and (iv) clinical status prediction of a subject based on his/her longitudinal imaging biomarkers. Notably, the learnable parameters of all the modules in our predictive models are trained in an end-to-end manner by taking the morphological features and cognitive scores as input, with our circumspectly defined loss function. In our experiments over The Alzheimers Disease Prediction Of Longitudinal Evolution (TADPOLE) challenge cohort, we measured performance for various metrics and compared our method to competing methods in the literature. Exhaustive analyses and ablation studies were also conducted to better confirm the effectiveness of our method.

Citing Articles

Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer's Disease research.

Wang H, Shi C, Jiang L, Liu X, Tang R, Tang M Front Aging Neurosci. 2024; 16:1485657.

PMID: 39691161 PMC: 11649678. DOI: 10.3389/fnagi.2024.1485657.


Longitudinal Alzheimer's Disease Progression Prediction With Modality Uncertainty and Optimization of Information Flow.

Dao D, Yang H, Kim J, Ho N IEEE J Biomed Health Inform. 2024; 29(1):259-272.

PMID: 39356605 PMC: 11875883. DOI: 10.1109/JBHI.2024.3472462.


Machine learning in neurological disorders: A multivariate LSTM and AdaBoost approach to Alzheimer's disease time series analysis.

Irfan M, Shahrestani S, Elkhodr M Health Care Sci. 2024; 3(1):41-52.

PMID: 38939169 PMC: 11080865. DOI: 10.1002/hcs2.84.


Deep learning model for individualized trajectory prediction of clinical outcomes in mild cognitive impairment.

Jung W, Kim S, Kim J, Jang H, Park C, Kim H Front Aging Neurosci. 2024; 16:1356745.

PMID: 38813529 PMC: 11135285. DOI: 10.3389/fnagi.2024.1356745.


Sporadic cerebral small vessel disease and cognitive decline in healthy older adults: A systematic review and meta-analysis.

Jansma A, de Bresser J, Schoones J, van Heemst D, Akintola A J Cereb Blood Flow Metab. 2024; 44(5):660-679.

PMID: 38415688 PMC: 11197143. DOI: 10.1177/0271678X241235494.